Malignant Arrhythmias in Acute Myocardial Infarction. Relationship to Serum Potassium and Effect of Selective and Non-selective Beta-blockade

Overview

Journal Drugs

Specialty Pharmacology

Date 1984 Oct 1

PMID 6149923

Citations 8

Authors

B W Johansson

R Dziamski

Affiliations

Soon will be listed here.

Abstract

The risk of malignant arrhythmias during myocardial infarction is greatly increased in patients with diuretic-induced hypokalaemia. In our study an increased risk was seen also in hypokalaemic patients not treated with diuretics. This indicates that hypokalaemia as such could trigger malignant arrhythmias. The frequency of hypokalaemia was much higher (22.5%) in diuretic-treated infarct patients than in those not treated with diuretics (12.9%). Thus, hypokalaemia should be avoided in diuretic-treated patients with increased risk of myocardial infarction. The incidence of malignant arrhythmias in hypokalaemic patients was 13.2% in those treated with non-selective beta-blockers on admission versus 26.1% in those treated with selective beta-blockers; corresponding figures in infarctions with serum potassium concentrations above 3.6 mmol/L were 9.4% and 10.4%, respectively. Non-selective beta-blockers reduced the frequency of malignant arrhythmias in hypokalaemic infarctions. This was in contrast to selective beta-blockers, which had no favourable effect on the frequency of malignant arrhythmias in hypokalaemic infarctions. Non-selective beta-blockers did not completely counteract the hypokalaemia. Still, the risk of malignant arrhythmias decreased. Thus, our study indicates that apart from hypokalaemia, some additional mechanism specifically linked to adrenaline stimulation in important for the development of malignant arrhythmias in acute myocardial infarction.

Citing Articles

Arrhythmogenic Mechanisms in Hypokalaemia: Insights From Pre-clinical Models.

Tse G, Li K, Cheung C, Letsas K, Bhardwaj A, Sawant A Front Cardiovasc Med. 2021; 8:620539.

PMID: 33614751 PMC: 7887296. DOI: 10.3389/fcvm.2021.620539.

Admission serum potassium level is associated with in-hospital and long-term mortality in ST-elevation myocardial infarction.

Uluganyan M, Ekmekci A, Murat A, Avsar S, Ulutas T, Uyarel H Anatol J Cardiol. 2015; 16(1):10-5.

PMID: 26467357 PMC: 5336698. DOI: 10.5152/akd.2015.5706.

pre-operative serum potassium levels and peri-operative outcomes in patients undergoing cardiac surgery.

Sanjay O Indian J Clin Biochem. 2012; 19(1):40-4.

PMID: 23105424 PMC: 3453902. DOI: 10.1007/BF02872387.

Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, Sweden.

Merlo J, Hedblad B, Ogren M, Ranstam J, Ostergren P, Ekedahl A Eur J Clin Pharmacol. 1996; 49(4):261-5.

PMID: 8857070 DOI: 10.1007/BF00226325.

Potassium and anaesthesia.

Tetzlaff J, OHara Jr J, Walsh M Can J Anaesth. 1993; 40(3):227-46.

PMID: 8467545 DOI: 10.1007/BF03037035.

References

. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group. JAMA. 1981; 246(18):2073-4. View

Struthers A, Reid J, Whitesmith R, Rodger J . The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci (Lond). 1983; 65(2):143-7. DOI: 10.1042/cs0650143. View

Hansteen V, MOINICHEN E, Lorentsen E, Andersen A, Strom O, Soiland K . One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed). 1982; 284(6310):155-60. PMC: 1495539. DOI: 10.1136/bmj.284.6310.155. View

Bertel O, Buhler F, Baitsch G, Ritz R, Burkart F . Plasma adrenaline and noradrenaline in patients with acute myocardial infarction. Relationship to ventricular arrhythmias of varying severity. Chest. 1982; 82(1):64-8. DOI: 10.1378/chest.82.1.64. View

Frishman W, Furberg C, FRIEDEWALD W . Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med. 1984; 310(13):830-7. DOI: 10.1056/NEJM198403293101306. View

. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med. 1984; 310(1):9-15. DOI: 10.1056/NEJM198401053100103. View

DSilva J . The action of adrenaline on serum potassium. J Physiol. 1934; 82(4):393-8. PMC: 1394283. DOI: 10.1113/jphysiol.1934.sp003190. View

Struthers A, Whitesmith R, Reid J . Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet. 1983; 1(8338):1358-61. DOI: 10.1016/s0140-6736(83)92140-2. View

. Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. Br Med J. 1975; 3(5986):735-40. PMC: 1674632. DOI: 10.1136/bmj.3.5986.735. View

10.

Clausen T . Adrenergic control of Na+-K+-homoeostasis. Acta Med Scand Suppl. 1983; 672:111-5. DOI: 10.1111/j.0954-6820.1983.tb01622.x. View

11.

Clausen T, Flatman J . Beta 2-adrenoceptors mediate the stimulating effect of adrenaline on active electrogenic Na-K-transport in rat soleus muscle. Br J Pharmacol. 1980; 68(4):749-55. PMC: 2044229. DOI: 10.1111/j.1476-5381.1980.tb10868.x. View

12.

. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981; 304(14):801-7. DOI: 10.1056/NEJM198104023041401. View

13.

Hjalmarson A . Acute intervention with metoprolol in myocardial infarction. Acta Med Scand Suppl. 1981; 651:177-84. DOI: 10.1111/j.0954-6820.1981.tb03654.x. View

14.

Robberecht P, Delhaye M, Taton G, De Neef P, Waelbroeck M, De Smet J . The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors. Mol Pharmacol. 1983; 24(2):169-73. View

15.

Struthers A, Reid J . The role of adrenal medullary catecholamines in potassium homoeostasis. Clin Sci (Lond). 1984; 66(4):377-82. DOI: 10.1042/cs0660377. View

16.

Ceremuzynski L, STASZEWSKA-BARCZAK J . Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc Res. 1969; 3(2):190-7. DOI: 10.1093/cvr/3.2.190. View

17.

Brown M, Brown D, Murphy M . Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983; 309(23):1414-9. DOI: 10.1056/NEJM198312083092303. View

18.

Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G . Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet. 1981; 2(8251):823-7. DOI: 10.1016/s0140-6736(81)91101-6. View

19.

Hulting J . In-hospital ventricular fibrillation and its relation to serum potassium. Acta Med Scand Suppl. 1981; 647:109-16. DOI: 10.1111/j.0954-6820.1981.tb02646.x. View